Original news and analysis on international IP policy
Dar es Salaam, Tanzania - In a re-cast, smaller version of the event that was planned and postponed last year, the US State Department’s workshop on IP utilisation and protection in Africa opened yesterday. It is co-organised by the African Intellectual Property Group (AIPG), a new pro-IP association of stakeholders across the continent, which says it’s time for Africa find its own voice on intellectual property issues.
Indian negotiators are reportedly under tremendous pressure to give in to the European demands for a more rigid intellectual property rights regime in the ongoing discussions on EU-India free trade agreement, suggests a leaked draft text of the chapter on IP which is being negotiated.
In its meeting this week, the World Trade Organisation intellectual property committee heard again about the issue of plain packaging of tobacco products, as New Zealand is proposing to introduce such a regime in the country. Economic and health interests were used by those opposed and proponents to the measure.
The World Trade Organization committee on intellectual property rights met this week and addressed a request by least developed countries for an extension of the period to enforce WTO intellectual property rules. LDCs want that the extension be extinguishable only after a country ceases to be considered as 'least developed', which developing countries largely supported. Developed countries, however, were hesitant about the terms of the proposed extension.
New Delhi - India’s Intellectual Property Appellate Board (IPAB) today upheld the country’s first compulsory licence on a pharmaceutical product. The much-awaited verdict by Justice (Ms) Prabha Sridevan upholds the compulsory licence issued to Hyderabad-based Natco Pharma Ltd, an Indian generic drug manufacturer, which sells a much cheaper version of German pharmaceutical company Bayer AG's kidney and liver cancer drug Nexavar in the market.
Nick Ashton-Hart writes: Some of you may have noticed that the ICT sector trade association that I represent in Geneva, the Computer and Communication Industry Association (CCIA), has endorsed a bid by the world’s Least Developed Countries (LDC’s) to remove any specific deadline for full compliance with the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement.
The role of intellectual property in a wide range of public health challenges - access to medicines, vaccine prices, procurement strategies, and research for diseases of the poor - is a focal point in 2013 cutting across national, regional, and international policymaking.
Least developed countries next week will ask that World Trade Organization members grant them another extension of the transition period to enforce intellectual property protection measures beyond the current date of 1 July 2013. In addition, the issues of plain packaging for tobacco products and innovation will be back on the agenda of the WTO intellectual property committee.
The United Nations has become a focal point for global efforts to fight organised crime’s trafficking of fraudulent medicines that put millions of people – especially the poor – at risk. And a recent pharmaceutical industry report on such medicines recommended some solutions.
A 2011 letter from the top Republican on the United States Senate Finance Committee condemned efforts by the Global Fund to train public health officials on the use of flexibilities to the patent system contained in international trade rules. The letter, which also attacked the purchase of generic medicines over brand-name drugs, came just months before the US helped remove the head of the Global Fund, ultimately replacing him with an American official.